(Q36859052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Sara K Evans

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Michael R Green

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

23 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

Journal of Molecular Medicine

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1175-1186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00109-007-0221-2

1 January 2020

exact match

0 references

cites work

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0221-2

Prolyl 4-hydroxylase isoenzymes I and II have different expression patterns in several human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0221-2

Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0221-2

Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0221-2

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0221-2

The p53 tumor suppressor gene inhibits angiogenesis by stimulating the production of thrombospondin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-007-0221-2

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

12 December 2020

Cyclooxygenase-2: a therapeutic target in angiogenesis.

1 reference

12 December 2020

p53 cannot be induced by hypoxia alone but responds to the hypoxic microenvironment

1 reference

12 December 2020

p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase

1 reference

12 December 2020

Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis

1 reference

12 December 2020

p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis

1 reference

12 December 2020

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

1 reference

12 December 2020

Thrombospondin-1 is a major activator of TGF-beta1 in vivo

1 reference

12 December 2020

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

1 reference

12 December 2020

Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis

1 reference

12 December 2020

Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway

1 reference

12 December 2020

Regulation of tumor angiogenesis by thrombospondin-1.

1 reference

12 December 2020

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells

1 reference

12 December 2020

Transcriptional repression mediated by the p53 tumour suppressor

1 reference

12 December 2020

Anti-angiogenic cues from vascular basement membrane collagen

1 reference

12 December 2020

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

12 December 2020

Collagens: molecular biology, diseases, and potentials for therapy

1 reference

12 December 2020

Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma

1 reference

12 December 2020

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

1 reference

12 December 2020

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

12 December 2020

The inhibition of tumor growth by tumor mass

1 reference

12 December 2020

Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice.

1 reference

12 December 2020

Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells

1 reference

12 December 2020

Neoangiogenesis in colon cancer: correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression

1 reference

12 December 2020

Downmodulation of bFGF-binding protein expression following restoration of p53 function

1 reference

12 December 2020

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

12 December 2020

A global map of p53 transcription-factor binding sites in the human genome

1 reference

12 December 2020

Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis

1 reference

12 December 2020

Basement membranes: structure, assembly and role in tumour angiogenesis

1 reference

12 December 2020

Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo.

1 reference

12 December 2020

Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts

1 reference

12 December 2020

Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.

1 reference

12 December 2020

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

1 reference

12 December 2020

A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis

1 reference

12 December 2020

Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

p53 mutations in human cancers

1 reference

12 December 2020

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

12 December 2020

Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis

1 reference

12 December 2020

Live or let die: the cell's response to p53

1 reference

12 December 2020

In cultured astrocytes, p53 and MDM2 do not alter hypoxia-inducible factor-1alpha function regardless of the presence of DNA damage

1 reference

12 December 2020

Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.

1 reference

12 December 2020

Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors

1 reference

12 December 2020

Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene.

1 reference

12 December 2020

A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network

1 reference

12 December 2020

Activation of the myc oncoprotein leads to increased turnover of thrombospondin-1 mRNA

1 reference

12 December 2020

Immunofluorescence localization of prolyl 4-hydroxylase isoenzymes and type I and II collagens in bone tumours: type I enzyme predominates in osteosarcomas and chondrosarcomas, whereas type II enzyme predominates in their benign counterparts

1 reference

12 December 2020

EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

1 reference

12 December 2020

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

1 reference

12 December 2020

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

1 reference

12 December 2020

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

12 December 2020

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

1 reference

12 December 2020

Inhibition of cyclooxygenase-2 gene expression by p53.

1 reference

12 December 2020

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

1 reference

12 December 2020

Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.

1 reference

12 December 2020

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

12 December 2020

Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity

1 reference

12 December 2020

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

1 reference

12 December 2020

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin

1 reference

12 December 2020

TGF-beta signaling in tumor suppression and cancer progression

1 reference

12 December 2020

Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

1 reference

12 December 2020

Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

1 reference

12 December 2020

Differential EphA2 epitope display on normal versus malignant cells

1 reference

12 December 2020

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

12 December 2020

p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma

1 reference

12 December 2020

Growth and metastasis of tumor in organ culture

1 reference

12 December 2020

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

1 reference

12 December 2020

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin

1 reference

12 December 2020

Radiation abscopal antitumor effect is mediated through p53

1 reference

12 December 2020

Tumorigenesis and the angiogenic switch

1 reference

12 December 2020

Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor

1 reference

12 December 2020

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

1 reference

12 December 2020

Eph receptor signalling casts a wide net on cell behaviour

1 reference

12 December 2020

DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.

1 reference

12 December 2020

The controversial abscopal effect

1 reference

12 December 2020

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

12 December 2020

Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms

1 reference

12 December 2020

Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma

1 reference

12 December 2020

p53, vessel count, and vascular endothelial growth factor expression in human colon cancer

1 reference

12 December 2020

Irradiation of a primary tumor, unlike surgical removal, enhances angiogenesis suppression at a distal site: potential role of host-tumor interaction

1 reference

12 December 2020

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

12 December 2020

Cancer without disease.

1 reference

12 December 2020

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis.

1 reference

12 December 2020

Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study

1 reference

12 December 2020

Decreased tumorigenic potential of EphA2-overexpressing breast cancer cells following treatment with adenoviral vectors that express EphrinA1.

1 reference

12 December 2020

Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1.

1 reference

12 December 2020

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

1 reference

12 December 2020

High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours

1 reference

12 December 2020

The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinoma

1 reference

12 December 2020

New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo.

1 reference

12 December 2020

Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha

1 reference

12 December 2020

10.1007/S00109-007-0221-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17589818%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference